GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Mitsubishi UFJ Trust & Banking Corp

Mitsubishi UFJ Trust & Banking Corp reduced its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 5.0% in the third quarter, Holdings Channel.com reports. The institutional investor owned 232,629 shares of the company’s stock after selling 12,149 shares during the period. Mitsubishi UFJ Trust & Banking Corp’s holdings in GE HealthCare Technologies were worth $15,828,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently added to or reduced their stakes in the company. First Command Advisory Services Inc. grew its stake in GE HealthCare Technologies by 36,900.0% during the 3rd quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock worth $25,000 after buying an additional 369 shares during the last quarter. Pin Oak Investment Advisors Inc. bought a new position in shares of GE HealthCare Technologies in the second quarter worth $25,000. Center for Financial Planning Inc. bought a new position in shares of GE HealthCare Technologies in the second quarter worth $26,000. Householder Group Estate & Retirement Specialist LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. Finally, Legacy Financial Group LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth $26,000. 79.18% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Up 2.2 %

Shares of GE HealthCare Technologies stock opened at $83.17 on Tuesday. The stock has a 50-day moving average price of $75.32 and a 200 day moving average price of $71.27. The company has a market cap of $37.87 billion and a P/E ratio of 27.54. The company has a current ratio of 1.05, a quick ratio of 0.83 and a debt-to-equity ratio of 1.18. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $87.83.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last announced its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. The firm had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 EPS. As a group, analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 16th will be paid a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date of this dividend is Friday, January 12th. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on GEHC. Mizuho increased their price target on GE HealthCare Technologies from $94.00 to $96.00 and gave the stock a “buy” rating in a research note on Wednesday, February 7th. Jefferies Financial Group began coverage on GE HealthCare Technologies in a report on Thursday, November 30th. They issued a “hold” rating and a $80.00 price objective for the company. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their price objective for the company from $66.00 to $88.00 in a report on Monday. Finally, Morgan Stanley upped their price objective on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a report on Monday. Five equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $87.82.

View Our Latest Stock Analysis on GE HealthCare Technologies

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally.

Featured Articles

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.